Expression of Carboxypeptidase A3 and Tryptase as Markers for Lymph Node Metastasis of Canine Cutaneous Mast Cell Tumors

Detection of metastatic mast cell tumors (MCTs) in lymph nodes is a critical factor for treatment, prognosis, and clinical management. Presence/absence of mast cells in the lymph nodes cannot be used as a sole parameter to determine metastasis due to the inability to differentiate neoplastic from no...

Full description

Bibliographic Details
Main Authors: Tuddow Thaiwong, Juliana V. Cirillo, Jane Heller, Matti Kiupel
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Veterinary Science
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2022.815658/full
_version_ 1818330487669653504
author Tuddow Thaiwong
Juliana V. Cirillo
Jane Heller
Matti Kiupel
Matti Kiupel
author_facet Tuddow Thaiwong
Juliana V. Cirillo
Jane Heller
Matti Kiupel
Matti Kiupel
author_sort Tuddow Thaiwong
collection DOAJ
description Detection of metastatic mast cell tumors (MCTs) in lymph nodes is a critical factor for treatment, prognosis, and clinical management. Presence/absence of mast cells in the lymph nodes cannot be used as a sole parameter to determine metastasis due to the inability to differentiate neoplastic from non-neoplastic/inflammatory mast cells. While cytologic and histopathologic classifications for assessment of metastatic MCTs based on the numbers and distribution of mast cells have been developed, inconsistency between the clinical interpretation of these grading schemes and actual metastatic status occurs. The aim of this study is to identify a novel diagnostic tool to accurately predict overt metastatic mast cell tumors in lymph nodes. We investigated the possibility of using RT-qPCR to detect mRNA expression of mast cell-specific genes in lymph nodes with different stages of MCT metastatic classification. We are able to establish a highly sensitive and discriminating RT-qPCR measuring Carboxy peptidase A3 (CPA3) and tryptase mRNA expression and identify the cut-off values with high sensitivity and specificity for overt metastatic MCTs in lymph nodes. An area of future interest would be to expand our analysis of the extent to which cut-off values for these markers in correctly identifying disease status, as well as predicting clinical outcomes and survival times. This would offer valuable information regarding the practical applicability of this technique and may enable us to improve our standards of detection metastasis, including possibility of molecular analysis of cytologic specimens obtained from suspicious nodes subjected to surgical excision.
first_indexed 2024-12-13T13:04:44Z
format Article
id doaj.art-c598122e723d4e4fba812e366263f1b2
institution Directory Open Access Journal
issn 2297-1769
language English
last_indexed 2024-12-13T13:04:44Z
publishDate 2022-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Veterinary Science
spelling doaj.art-c598122e723d4e4fba812e366263f1b22022-12-21T23:44:51ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692022-02-01910.3389/fvets.2022.815658815658Expression of Carboxypeptidase A3 and Tryptase as Markers for Lymph Node Metastasis of Canine Cutaneous Mast Cell TumorsTuddow Thaiwong0Juliana V. Cirillo1Jane Heller2Matti Kiupel3Matti Kiupel4Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Michigan State University, Lansing, MI, United StatesDepartamento de Patologia, Facultad de Medicina Veterinaria y Zootecnia, Universidade de São Paulo, São Paulo, BrazilSchool of Animal and Veterinary Services, Faculty of Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW, AustraliaVeterinary Diagnostic Laboratory, College of Veterinary Medicine, Michigan State University, Lansing, MI, United StatesDepartment of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI, United StatesDetection of metastatic mast cell tumors (MCTs) in lymph nodes is a critical factor for treatment, prognosis, and clinical management. Presence/absence of mast cells in the lymph nodes cannot be used as a sole parameter to determine metastasis due to the inability to differentiate neoplastic from non-neoplastic/inflammatory mast cells. While cytologic and histopathologic classifications for assessment of metastatic MCTs based on the numbers and distribution of mast cells have been developed, inconsistency between the clinical interpretation of these grading schemes and actual metastatic status occurs. The aim of this study is to identify a novel diagnostic tool to accurately predict overt metastatic mast cell tumors in lymph nodes. We investigated the possibility of using RT-qPCR to detect mRNA expression of mast cell-specific genes in lymph nodes with different stages of MCT metastatic classification. We are able to establish a highly sensitive and discriminating RT-qPCR measuring Carboxy peptidase A3 (CPA3) and tryptase mRNA expression and identify the cut-off values with high sensitivity and specificity for overt metastatic MCTs in lymph nodes. An area of future interest would be to expand our analysis of the extent to which cut-off values for these markers in correctly identifying disease status, as well as predicting clinical outcomes and survival times. This would offer valuable information regarding the practical applicability of this technique and may enable us to improve our standards of detection metastasis, including possibility of molecular analysis of cytologic specimens obtained from suspicious nodes subjected to surgical excision.https://www.frontiersin.org/articles/10.3389/fvets.2022.815658/fullmast cell tumortryptasecarboxypeptidase A3prognosiscaninelymph node metastasis
spellingShingle Tuddow Thaiwong
Juliana V. Cirillo
Jane Heller
Matti Kiupel
Matti Kiupel
Expression of Carboxypeptidase A3 and Tryptase as Markers for Lymph Node Metastasis of Canine Cutaneous Mast Cell Tumors
Frontiers in Veterinary Science
mast cell tumor
tryptase
carboxypeptidase A3
prognosis
canine
lymph node metastasis
title Expression of Carboxypeptidase A3 and Tryptase as Markers for Lymph Node Metastasis of Canine Cutaneous Mast Cell Tumors
title_full Expression of Carboxypeptidase A3 and Tryptase as Markers for Lymph Node Metastasis of Canine Cutaneous Mast Cell Tumors
title_fullStr Expression of Carboxypeptidase A3 and Tryptase as Markers for Lymph Node Metastasis of Canine Cutaneous Mast Cell Tumors
title_full_unstemmed Expression of Carboxypeptidase A3 and Tryptase as Markers for Lymph Node Metastasis of Canine Cutaneous Mast Cell Tumors
title_short Expression of Carboxypeptidase A3 and Tryptase as Markers for Lymph Node Metastasis of Canine Cutaneous Mast Cell Tumors
title_sort expression of carboxypeptidase a3 and tryptase as markers for lymph node metastasis of canine cutaneous mast cell tumors
topic mast cell tumor
tryptase
carboxypeptidase A3
prognosis
canine
lymph node metastasis
url https://www.frontiersin.org/articles/10.3389/fvets.2022.815658/full
work_keys_str_mv AT tuddowthaiwong expressionofcarboxypeptidasea3andtryptaseasmarkersforlymphnodemetastasisofcaninecutaneousmastcelltumors
AT julianavcirillo expressionofcarboxypeptidasea3andtryptaseasmarkersforlymphnodemetastasisofcaninecutaneousmastcelltumors
AT janeheller expressionofcarboxypeptidasea3andtryptaseasmarkersforlymphnodemetastasisofcaninecutaneousmastcelltumors
AT mattikiupel expressionofcarboxypeptidasea3andtryptaseasmarkersforlymphnodemetastasisofcaninecutaneousmastcelltumors
AT mattikiupel expressionofcarboxypeptidasea3andtryptaseasmarkersforlymphnodemetastasisofcaninecutaneousmastcelltumors